Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ro Mah Huan"'
Autor:
Pieter Guetens, Erin Sauve, Nguyen Van Hong, Anna Rosanas-Urgell, Ro Mah Huan, Nguyen Thi Hong Ngọc, Nguyen Thi Huong Binh, Nguyen Thị Thu Hien, Nguyen Duc Long, Johanna Helena Kattenberg, Annette Erhart, Eduard Rovira-Vallbona, Nguyen Luong Hieu, Nguyen Xuan Xa, Vu Thi Sang, Tran Thanh Duong
Publikováno v:
Antimicrobial Agents and Chemotherapy. 65
Chloroquine (CQ) is the first-line treatment for Plasmodium vivax malaria in most countries where malaria is endemic. Monitoring P. vivax CQ resistance (CQR) is critical but remains challenged by the difficulty to distinguish real treatment failure f
Autor:
Eduard, Rovira-Vallbona, Nguyen, Van Hong, Johanna H, Kattenberg, Ro Mah, Huan, Nguyen Thi Huong, Binh, Nguyen Thi Hong, Ngọc, Pieter, Guetens, Nguyen Luong, Hieu, Nguyen Thị Thu, Hien, Vu Thi, Sang, Nguyen Duc, Long, Erin, Sauve, Tran Thanh, Duong, Nguyen Xuan, Xa, Annette, Erhart, Anna, Rosanas-Urgell
Publikováno v:
Antimicrob Agents Chemother
Chloroquine (CQ) is the first-line treatment for Plasmodium vivax malaria in most countries where malaria is endemic. Monitoring P. vivax CQ resistance (CQR) is critical but remains challenged by the difficulty to distinguish real treatment failure f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nguyen Xuan Xa, Nguyen Thi Huong Binh, Ro Mah Huan, Nguyen Duc Long, Tran Thanh Duong, Pieter Guetens, Anna Rosanas-Urgell, Nguyen Thi Hong Ngọc, Vu Thi Sang, Eduard Rovira-Vallbona, Nguyen Van Hong, Johanna H Kattenberg, Nguyen Luong Hieu, Annette Erhart, Erin Sauve, Nguyen Thị Thu Hien
Chloroquine (CQ) is the first-line treatment for Plasmodium vivax malaria in most endemic countries. Monitoring P.vivax CQ resistance (CQR) is critical but remains challenged by the difficulty to distinguish real treatment failure from reinfection or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f326f287451b0400758924337f2faac2
https://doi.org/10.1101/2021.01.22.21250265
https://doi.org/10.1101/2021.01.22.21250265
Autor:
Nguyen Thi Hong Ngoc, Bui Quang Phuc, Tran Thanh Duong, Johanna Helena Kattenberg, Nguyen Luong Hieu, Nguyen Van Hong, Nguyen Thi Thuy Duong, Annette Erhart, Tran Tuyet Mai, Anna Rosanas-Urgell, Nguyen Xuan Xa, Eduard Rovira-Vallbona, Nguyen Thu Hien, Pieter Guetens, Ro Mah Huan
Publikováno v:
J Antimicrob Chemother
Background Artemisinin-based combination therapies (ACTs) have significantly contributed to reduce Plasmodium falciparum malaria burden in Vietnam, but their efficacy is challenged by treatment failure of dihydroartemisinin/piperaquine ACT in Souther